The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 37,157 | 13,864,383 | SH | SOLE | 1,2 | 13,864,383 | 0 | 0 | |
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 75,149 | 6,320,350 | SH | SOLE | 1,2 | 6,320,350 | 0 | 0 | |
AGENUS INC | COM NEW | 00847G705 | 30,253 | 10,084,214 | SH | SOLE | 1,2 | 10,084,214 | 0 | 0 | |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 159,494 | 2,198,094 | SH | SOLE | 1,2 | 2,198,094 | 0 | 0 | |
ANCHIANO THERAPEUTICS LTD | SPONSORED ADS | 03280X102 | 233 | 51,918 | SH | SOLE | 1,2 | 51,918 | 0 | 0 | |
APYX MED CORP | COM | 03837C106 | 22,847 | 3,399,899 | SH | SOLE | 1,2 | 3,399,899 | 0 | 0 | |
ARBUTUS BIOPHARMA CORP | COM | 03879J100 | 11,509 | 5,533,093 | SH | SOLE | 1,2 | 5,533,093 | 0 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 4,452 | 31,448 | SH | SOLE | 1,2 | 31,448 | 0 | 0 | |
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 29,689 | 1,120,346 | SH | SOLE | 1,2 | 1,120,346 | 0 | 0 | |
ARVINAS INC | COM | 04335A105 | 17,765 | 807,870 | SH | SOLE | 1,2 | 807,870 | 0 | 0 | |
AXONICS MODULATION TECH INC | COM | 05465P101 | 62,873 | 1,534,605 | SH | SOLE | 1,2 | 1,534,605 | 0 | 0 | |
AXSOME THERAPEUTICS INC | COM | 05464T104 | 21,740 | 844,289 | SH | SOLE | 1,2 | 844,289 | 0 | 0 | |
BRAINSWAY LTD | SPONSORED ADS | 10501L106 | 6,263 | 597,216 | SH | SOLE | 1,2 | 597,216 | 0 | 0 | |
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 70,833 | 1,561,918 | SH | SOLE | 1,2 | 1,561,918 | 0 | 0 | |
CAREDX INC | COM | 14167L103 | 5,565 | 154,616 | SH | SOLE | 1,2 | 154,616 | 0 | 0 | |
CHARDAN HEALTHCARE ACQUISITI | UNIT 12/13/2023 | 15957A207 | 6,113 | 600,000 | SH | SOLE | 1,2 | 600,000 | 0 | 0 | |
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 11,089 | 988,319 | SH | SOLE | 1,2 | 988,319 | 0 | 0 | |
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 96,896 | 6,152,103 | SH | SOLE | 1,2 | 6,152,103 | 0 | 0 | |
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 41,411 | 1,883,180 | SH | SOLE | 1,2 | 1,883,180 | 0 | 0 | |
FLUIDIGM CORP DEL | COM | 34385P108 | 25,594 | 2,077,471 | SH | SOLE | 1,2 | 2,077,471 | 0 | 0 | |
HOMOLOGY MEDICINES INC | COM | 438083107 | 40,215 | 2,054,932 | SH | SOLE | 1,2 | 2,054,932 | 0 | 0 | |
ILLUMINA INC | COM | 452327109 | 30,188 | 82,000 | SH | SOLE | 1,2 | 82,000 | 0 | 0 | |
JOHNSON & JOHNSON | COM | 478160104 | 13,080 | 93,912 | SH | SOLE | 1,2 | 93,912 | 0 | 0 | |
LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 18,605 | 2,011,340 | SH | SOLE | 1,2 | 2,011,340 | 0 | 0 | |
MASIMO CORP | COM | 574795100 | 55,399 | 372,258 | SH | SOLE | 1,2 | 372,258 | 0 | 0 | |
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 90,967 | 3,521,856 | SH | SOLE | 1,2 | 3,521,856 | 0 | 0 | |
MIRATI THERAPEUTICS INC | COM | 60468T105 | 26,293 | 255,270 | SH | SOLE | 1,2 | 255,270 | 0 | 0 | |
MOTUS GI HLDGS INC | COM | 62014P108 | 3,412 | 1,126,144 | SH | SOLE | 1,2 | 1,126,144 | 0 | 0 | |
MYOKARDIA INC | COM | 62857M105 | 36,274 | 723,455 | SH | SOLE | 1,2 | 723,455 | 0 | 0 | |
MYRIAD GENETICS INC | COM | 62855J104 | 10,462 | 376,586 | SH | SOLE | 1,2 | 376,586 | 0 | 0 | |
NEURONETICS INC | COM | 64131A105 | 2,105 | 168,274 | SH | SOLE | 1,2 | 168,274 | 0 | 0 | |
ODONATE THERAPEUTICS INC | COM | 676079106 | 12,444 | 339,156 | SH | SOLE | 1,2 | 339,156 | 0 | 0 | |
OPTINOSE INC | COM | 68404V100 | 620 | 87,615 | SH | SOLE | 1,2 | 87,615 | 0 | 0 | |
ORTHOPEDIATRICS CORP | COM | 68752L100 | 14,689 | 376,647 | SH | SOLE | 1,2 | 376,647 | 0 | 0 | |
PERSONALIS INC | COM | 71535D106 | 6,109 | 225,000 | SH | SOLE | 1,2 | 225,000 | 0 | 0 | |
PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 8,993 | 270,948 | SH | SOLE | 1,2 | 270,948 | 0 | 0 | |
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 33,879 | 3,722,950 | SH | SOLE | 1,2 | 3,722,950 | 0 | 0 | |
PTC THERAPEUTICS INC | COM | 69366J200 | 141,181 | 3,137,361 | SH | SOLE | 1,2 | 3,137,361 | 0 | 0 | |
QUOTIENT LTD | SHS | G73268107 | 14,437 | 1,544,047 | SH | SOLE | 1,2 | 1,544,047 | 0 | 0 | |
REGENXBIO INC | COM | 75901B107 | 18,906 | 368,040 | SH | SOLE | 1,2 | 368,040 | 0 | 0 | |
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 248,812 | 16,587,491 | SH | SOLE | 1,2,3 | 16,587,491 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 91,814 | 604,236 | SH | SOLE | 1,2 | 604,236 | 0 | 0 | |
SILK ROAD MEDICAL INC | COM | 82710M100 | 10,842 | 223,722 | SH | SOLE | 1,2 | 223,722 | 0 | 0 | |
SOLID BIOSCIENCES INC | COM | 83422E105 | 835 | 145,225 | SH | SOLE | 1,2 | 145,225 | 0 | 0 | |
STOKE THERAPEUTICS INC | COM | 86150R107 | 92,570 | 3,355,466 | SH | SOLE | 1,2 | 3,355,466 | 0 | 0 | |
TRANSLATE BIO INC | COM | 89374L104 | 30,808 | 2,439,250 | SH | SOLE | 1,2 | 2,439,250 | 0 | 0 | |
TRANSMEDICS GROUP INC | COM | 89377M109 | 14,698 | 507,007 | SH | SOLE | 1,2 | 507,007 | 0 | 0 | |
UNIQURE NV | SHS | N90064101 | 11,300 | 144,595 | SH | SOLE | 1,2 | 144,595 | 0 | 0 | |
VERICEL CORP | COM | 92346J108 | 49,242 | 2,606,771 | SH | SOLE | 1,2 | 2,606,771 | 0 | 0 | |
VIEWRAY INC | COM | 92672L107 | 1,403 | 159,247 | SH | SOLE | 1,2 | 159,247 | 0 | 0 | |
VIVEVE MED INC | COM NEW | 92852W204 | 1,703 | 4,480,565 | SH | SOLE | 1,2 | 4,480,565 | 0 | 0 | |
Vivus Inc 4.5 05/01/2020 | NOTE 4.500% 5/0 | 928551AA8 | 3,128 | 4,000,000 | SH | SOLE | 1 | 4,000,000 | 0 | 0 |